Catalyst Funds Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.5K Buy
+11,117
New +$61.9K ﹤0.01% 626
2024
Q4
Sell
-18,800
Closed -$148K 1166
2024
Q3
$148K Sell
18,800
-1,700
-8% -$15.3K 0.03% 371
2024
Q2
$211K Sell
20,500
-1,100
-5% -$11.9K 0.06% 199
2024
Q1
$270K Buy
+21,600
New +$279K 0.08% 210

Other funds holding TBI

Catalyst Funds Management's TBI Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Trueblue (TBI) in Q2 2026: 11,117 shares worth $77.5K. The stake represents ﹤0.01% of the portfolio and ranks #626 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in TBI as recently as Q3 2024.

Catalyst Funds Management first reported a position in TBI in Q1 2024 and has held it in 4 quarters since. The position peaked at $270K in Q1 2024. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Catalyst Funds Management held 11,117 shares of Trueblue worth $77.5K as of Q2 2026.
  • Trueblue was a new Catalyst Funds Management position in Q2 2026.
  • Trueblue made up ﹤0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #626 holding.
  • Catalyst Funds Management first reported a position in Trueblue in Q1 2024 and has held it in 4 quarters since.
  • Catalyst Funds Management's Trueblue position peaked at $270K in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.